Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study.
Eliane Matos Dos SantosTatiana Guimarães NoronhaIsabelle Soares AlvesRobson Leite de Souza CruzClara Lucy de Vasconcellos FerrocoRicardo Cristiano BrumPatricia Mouta Nunes de OliveiraMarilda Mendonça SiqueiraMariza Cristina LimaFrancisco Luzio de Paula RamosCamila de Marco BragagnoloLuiz Antonio Bastos CamachoMaria de Lourdes de Sousa MaiaPublished in: Memorias do Instituto Oswaldo Cruz (2019)
The demonstration of batch consistency and non-inferiority of the Bio-MMR vaccine completed the technology transfer. This is a significant technological achievement with implications for immunisation programs.